BRIEF-Intersect ENT announces FDA submission of NOVA

* Intersect ENT announces FDA submission of NOVA

bioabsorbable steroid releasing implant for patients with

chronic sinus disease

Source text for Eikon:

Further company coverage:

(Bengaluru...

Read more